Timothy Wilkin

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial

José Valdez Madruga, Pedro Cahn, Beatriz Grinsztejn et al. · The Lancet · 2007 · 515 citations

Treatment-experienced Hiv-1-infected Patients, Treatment And Prevention, Human Retrovirus +11

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

Bonaventura Clotet, Nicholas Bellos, Jean‐Michel Molina et al. · The Lancet · 2007 · 480 citations

Treatment And Prevention, Week 48, Antiviral Drug Development +9

Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer

Joel M. Palefsky, Jeannette Y. Lee, Naomi Jay et al. · New England Journal of Medicine · 2022 · 436 citations · Full text

Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV‐1–Infected, Treatment‐Experienced Patients: AIDS Clinical Trials Group 5211

Roy M. Gulick, Zhaohui Su, Charles Flexner et al. · The Journal of Infectious Diseases · 2007 · 239 citations · Full text

Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV‐1–Infected Men

Timothy Wilkin, Jeannette Y. Lee, Shelly Lensing et al. · The Journal of Infectious Diseases · 2010 · 233 citations · Full text